Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: HEAD AND NECK NEOPLASMS - METABOLISM , . Treffer: 17

2018

Kreuter, A; Pantelaki, I; Michalowitz, AL; Wieland, U; Cerroni, L; Oellig, F; Tigges, C CD30-positive primary cutaneous anaplastic large cell lymphoma with coexistent pseudocarcinomatous hyperplasia.
Clin Exp Dermatol. 2018; 43(5):585-588 Doi: 10.1111/ced.13416 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2017

Kadletz, L; Thurnher, D; Wiebringhaus, R; Erovic, BM; Kotowski, U; Schneider, S; Schmid, R; Kenner, L; Heiduschka, G Role of cancer stem-cell marker doublecortin-like kinase 1 in head and neck squamous cell carcinoma.
Oral Oncol. 2017; 67(6):109-118 Doi: 10.1016/j.oraloncology.2017.02.007
Web of Science PubMed FullText FullText_MUG

 

2014

Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, AL; Koller, K; Salzwimmer, M; Gerger, A; Schauer, S; Bauernhofer, T; Pichler, M Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.
Hum Pathol. 2014; 45(4):683-690 Doi: 10.1016/j.humpath.2013.11.014
Web of Science PubMed FullText FullText_MUG

 

2013

Lill, C; Schneider, S; Ghanim, B; Brunner, M; Heiduschka, G; Loewe, R; Thurnher, D Expression of β-catenin and cyclin D1 in Merkel cell carcinomas of the head and neck.
Wien Klin Wochenschr. 2013; 125(17-18):501-507 Doi: 10.1007/s00508-013-0406-3
Web of Science PubMed FullText FullText_MUG

 

2012

Zielinski, V; Brunner, M; Heiduschka, G; Schneider, S; Seemann, R; Erovic, B; Thurnher, D ADAM8 in squamous cell carcinoma of the head and neck: a retrospective study.
BMC Cancer. 2012; 12(6):76-76 Doi: 10.1186/1471-2407-12-76 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Schneider, S; Thurnher, D; Kloimstein, P; Leitner, V; Petzelbauer, P; Pammer, J; Brunner, M; Erovic, BM Expression of the Sonic hedgehog pathway in squamous cell carcinoma of the skin and the mucosa of the head and neck.
Head Neck. 2011; 33(2):244-250 Doi: 10.1002/hed.21437
Web of Science PubMed FullText FullText_MUG

 

2010

Brunner, M; Erovic, B; Heiduschka, G; Schneider, S; Pammer, J; Frantal, S; Thurnher, D RCAS-1 serum and tumor levels in head and neck squamous cell carcinoma.
Eur Surg Res. 2010; 44(3-4):214-219 Doi: 10.1159/000314613
Web of Science PubMed FullText FullText_MUG

 

Brunner, M; Thurnher, D; Pammer, J; Heiduschka, G; Petzelbauer, P; Schmid, C; Schneider, S; Erovic, BM Expression of hedgehog signaling molecules in Merkel cell carcinoma.
Head Neck. 2010; 32(3):333-340 Doi: 10.1002/hed.21191
Web of Science PubMed FullText FullText_MUG

 

Haas, HS; Linecker, A; Pfragner, R; Sadjak, A Peripheral glutamate signaling in head and neck areas.
Head Neck. 2010; 32(11): 1554-1572. Doi: 10.1002/hed.21438
Web of Science PubMed FullText FullText_MUG

 

2009

Vormittag, L; Thurnher, D; Geleff, S; Pammer, J; Heiduschka, G; Brunner, M; Grasl, MCh; Erovic, BM Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy.
Int J Radiat Oncol Biol Phys. 2009; 73(3):913-918 Doi: 10.1016/j.ijrobp.2008.10.040
Web of Science PubMed FullText FullText_MUG

 

2008

Skoda, C; Erovic, BM; Wachek, V; Vormittag, L; Wrba, F; Martinek, H; Heiduschka, G; Kloimstein, P; Selzer, E; Thurnher, D Down-regulation of Mcl-1 with antisense technology alters the effect of various cytotoxic agents used in treatment of squamous cell carcinoma of the head and neck.
Oncol Rep. 2008; 19(6):1499-1503
Web of Science PubMed

 

2007

Frenzel, H; Hoffmann, B; Brocks, C; Schlenke, P; Pries, R; Wollenberg, B Toll-like receptor interference in myeloid dendritic cells through head and neck cancer.
Anticancer Res. 2007; 26(6B):4409-4413 [OPEN ACCESS]
Web of Science PubMed

 

2005

Czembirek, C; Eder-Czembirek, C; Erovic, BM; Turhani, D; Selzer, E; Thurnher, D Inhibition of cytotoxicity of cisplatin by cyclooxygenase-2 inhibitor nimesulide in head and neck cancer cell lines.
Oncol Rep. 2005; 14(6):1523-1526 Doi: 10.3892/or.14.6.1523
Web of Science PubMed FullText FullText_MUG

 

Eder-Czembirek, C; Czembirek, C; Erovic, BM; Selzer, E; Turhani, D; Vormittag, L; Thurnher, D Combination of betulinic acid with cisplatin--different cytotoxic effects in two head and neck cancer cell lines.
Oncol Rep. 2005; 14(3):667-671 Doi: 10.3892/or.14.3.667
Web of Science PubMed FullText FullText_MUG

 

Lamm, W; Vormittag, L; Turhani, D; Erovic, BM; Czembirek, C; Eder-Czembirek, C; Thurnher, D The effect of nimesulide, a selective cyclooxygenase-2 inhibitor, on Ets-1 and Ets-2 expression in head and neck cancer cell lines.
Head Neck. 2005; 27(12):1068-1072 Doi: 10.1002/hed.20285
Web of Science PubMed FullText FullText_MUG

 

Vormittag, L; Lamm, W; Erovic, BM; Czembirek, C; Kornek, G; Thurnher, D Expression levels of Akt in nimesulide-treated squamous carcinoma cell lines of the head and neck.
Oncol Rep. 2005; 13(2):207-210
Web of Science PubMed

 

1987

Kärcher, H; McNally, NJ; Wilson, G; Kärcher, KH; Pfragner, R In-vivo marking of human tumors using BUDR for flow-cytometry determination of kinetic cell parameters
Strahlenther Onkol. 1987; 163(3): 195-200.
Web of Science PubMed Google Scholar

 

© Med Uni Graz Impressum